We are live on
!
Find out more
SM
Sabby Management Portfolio holdings
AUM
$111M
1-Year Est. Return
74.4%
This Fund
S&P 500
This Quarter
Est. Return
-1.9%
1 Year Est. Return
-74.4%
3 Year Est. Return
-95.55%
5 Year Est. Return
-99.44%
10 Year Est. Return
-99.5%
AUM
$647M
AUM Growth
-$194M
(-23%)
Cap. Flow
+$33.7M
Cap. Flow
% of AUM
5.2%
Top 10 Holdings %
Top 10 Hldgs %
63.34%
Holding
208
New
51
Increased
38
Reduced
42
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$20.4M |
| 2 |
Nektar Therapeutics
NKTR
|
+$14.1M |
| 3 |
Xeris Biopharma Holdings
XERS
|
+$8.7M |
| 4 |
ESPR
Esperion Therapeutics
ESPR
|
+$6.56M |
| 5 |
NTBL
Notable Labs, Ltd. Ordinary Shares
NTBL
|
+$4.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$12M |
| 2 |
Biogen
BIIB
|
+$8.66M |
| 3 |
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
|
+$3.63M |
| 4 |
Cogent Biosciences
COGT
|
+$3.16M |
| 5 |
Incyte
INCY
|
+$2.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 73.46% |
| 2 | Healthcare | 26.22% |
| 3 | Consumer Staples | 0.17% |
| 4 | Financials | 0.05% |
| 5 | Industrials | 0.05% |
Similar funds
IWA
BFA
WPWM
BCM
ZS
KC
FI
CIM
Sabby Management's Q2 2018 Portfolio in Review
As of Q2 2018, Sabby Management held 208 positions worth $647M, down 23% from $841M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Sabby Management deployed $33.7M of net new capital in Q2 2018, opening 51 new positions and adding to 38 existing holdings. Its largest new stake was Novo Nordisk: 858,710 shares worth $19.8M.
By sector, the portfolio is most concentrated in Miscellaneous at 73% of assets, down from 83% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was Biogen, an estimated $8.66M trimmed.
- Sabby Management's largest Q2 2018 buy was Novo Nordisk: 858,710 shares worth $19.8M.
- Sabby Management added most to Nektar Therapeutics in Q2 2018, an estimated $14.1M increase.
- Sabby Management's biggest Q2 2018 reduction was Biogen, cutting an estimated $8.66M.
- Sabby Management fully exited State Street SPDR S&P 500 ETF Trust in Q2 2018, selling an estimated $12M.
- Sabby Management's ten largest holdings make up 63% of its $647M portfolio in Q2 2018.
- Sabby Management opened 51 new positions and closed 71 in Q2 2018.
- Sabby Management's portfolio value fell 23% quarter-over-quarter to $647M.
Based on Sabby Management's 13F filing for Q2 2018, filed 14 Aug 2018.